Clinical Trial Update: Microvascular Coronary Disease In Women: Impact Of Ranolazine [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the impact of ranolazine on microvascular coronary disease in women with myocardial ischemia; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Microvascular Coronary Disease
• Myocardial Ischemia

Drugs mentioned

• Ranolazine (ranolazine)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Myocardial Ischemia | Phase 2 | Status: COMPLETED | Results posted: 2015-12-03